Prognostic value of renal failure in patients undergoing transvenous lead extraction: single centre experience and systematic review of the literature

References

• Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable Cardioverter–Defibrillators. N Engl J Med. 2005;353(14):1471–1480.
   PubMed Web of Science ®Google Scholar
• Zabel M, Willems R, Lubinski A, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J. 2020;41(36):3437–3447.
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–1006.
   PubMed Web of Science ®Google Scholar
• Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48(3):590–591.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–477.
   PubMed Web of Science ®Google Scholar
• Blomstrom-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4):515–549.
   PubMed Web of Science ®Google Scholar
• Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767–777.
   PubMed Web of Science ®Google Scholar
• Tompkins C, McLean R, Cheng A, et al. End-stage renal disease predicts complications in pacemaker and ICD implants. J Cardiovasc Electrophysiol. 2011;22(10):1099–1104.
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237.
   PubMed Web of Science ®Google Scholar
• Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346(24):1854–1862.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–1338.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–883.
   PubMed Web of Science ®Google Scholar
• Diemberger I, Bonfiglioli R, Martignani C, et al. Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study. Eur J Nucl Med Mol Imaging. 2019;46(1):194–205.
   PubMed Web of Science ®Google Scholar
• Narui R, Nakajima I, Norton C, et al. Risk factors for repeat infection and mortality after extraction of infected cardiovascular implantable electronic devices. JACC Clin Electrophysiol. 2021;7(9):1182–1192.
   PubMedGoogle Scholar
• Diemberger I, Genovesi S, Massaro G, et al. Meta-analysis of clinical outcomes of electrical cardioversion and catheter ablation in patients with atrial fibrillation and chronic kidney disease. Curr Pharm Des. 2018;24(24):2794–2801.
   PubMed Web of Science ®Google Scholar
• Diemberger I, Massaro G, Reggiani MLB, et al. Outcomes with dronedarone in atrial fibrillation: what differences between real-world practice and trials? A meta-analysis and meta-regression analysis. Curr Pharm Des. 2017;23(6):944–951.
   PubMed Web of Science ®Google Scholar
• Diemberger I, Mazzotti A, Giulia MB, et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices. 2013;10(4):551–573.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Narducci ML, Di Monaco A, Pelargonio G, et al. Presence of ‘ghosts’ and mortality after transvenous lead extraction. Europace. 2017;19(3):432–440.
   PubMed Web of Science ®Google Scholar
• Barakat AF, Wazni OM, Tarakji KG, et al. Transvenous lead extraction in chronic kidney disease and dialysis patients with infected cardiac devices. Circ Arrhythm Electrophysiol. 2018;11(1):e005706.
   PubMed Web of Science ®Google Scholar
• Hickson LJ, Gooden JY, Le KY, et al. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. Am J Kidney Dis. 2014;64(1):104–110.
   PubMed Web of Science ®Google Scholar
• Jachec W, Polewczyk A, Polewczyk M, et al. Risk factors predicting complications of transvenous lead extraction. Biomed Res Int. 2018;2018:8796704.
   PubMed Web of Science ®Google Scholar
• Shah AD, Peddareddy LP, Addish MA, et al. Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease. Europace. 2017;19(12):1994–2000.
   PubMed Web of Science ®Google Scholar
• Tarakji KG, Wazni OM, Harb S, et al. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16(10):1490–1495.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128.
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E, Mattucci I, Agrusta F, et al. Current trends in the management of cardiac implantable electronic device (CIED) infections. Intern Emerg Med. 2013;8(6):465–476.
   PubMed Web of Science ®Google Scholar
• Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221–1230.
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–675.
   PubMedGoogle Scholar
• Diemberger I, Migliore F, Biffi M, et al. The “Subtle” connection between development of cardiac implantable electrical device infection and survival after complete system removal: an observational prospective multicenter study. Int J Cardiol. 2018;250:146–149.
   PubMed Web of Science ®Google Scholar
• Guha A, Maddox WR, Colombo R, et al. Cardiac implantable electronic device infection in patients with end-stage renal disease. Heart Rhythm. 2015;12(12):2395–2401.
   PubMed Web of Science ®Google Scholar
• Diemberger I, Segreti L, Rinaldi CA, et al. Transvenous lead extraction in patients with cardiac implantable device: the impact of systemic and local infection on clinical outcomes-an ESC-EHRA ELECTRa (European Lead Extraction Controlled) registry substudy. Biology (Basel). 2022;11(4):615.
   PubMedGoogle Scholar
• Bongiorni MG, Kennergren C, Butter C, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38(40):2995–3005.
   PubMed Web of Science ®Google Scholar
• Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55(6):579–586.
   PubMed Web of Science ®Google Scholar
• Di Cori A, Auricchio A, Regoli F, et al. Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Europace. 2019;21(7):1096–1105.
   PubMed Web of Science ®Google Scholar
• Pecha S, Burger H, Chung DU, et al. The German laser lead extraction registry: GALLERY. Europace. 2022;24(10):1627–1635.
   PubMed Web of Science ®Google Scholar
• Ai S, Liu J, Ma G, et al. Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge. Ann Med. 2022;54(1):754–763.
   PubMed Web of Science ®Google Scholar
• Takata T, Mae Y, Sugihara T, et al. Infective endocarditis-associated glomerulonephritis: a comprehensive review of the clinical presentation, histopathology, and management. Yonago Acta Med. 2022;65(1):1–7.
   PubMed Web of Science ®Google Scholar